DAUNORUBICIN CITRATE LIPOSOME 2MG/ML INJ (2820)    VA PRODUCT (50.68)

Name Value
NAME DAUNORUBICIN CITRATE LIPOSOME 2MG/ML INJ
VA GENERIC NAME DAUNORUBICIN
DOSAGE FORM INJ
HAZARDOUS TO DISPOSE NO
FORMULARY DESIGNATOR PA-F
FORMULARY DESIGNATOR TEXT 
Restrict to Hematology/Oncology
ACTIVE INGREDIENTS
NATIONAL FORMULARY INDICATOR YES
CS FEDERAL SCHEDULE Unscheduled
STRENGTH 2
SINGLE/MULTI SOURCE PRODUCT Single source
INACTIVATION DATE 2021-05-17 00:00:00
UNITS MG/ML
DSS NUMBER 2
NATIONAL FORMULARY NAME DAUNORUBICIN INJ
CREATE DEFAULT POSSIBLE DOSAGE NO
POSSIBLE DOSAGES TO CREATE No Possible Dosages
CODING SYSTEM
  • RxNorm
    CODE:
COPAY TIER
  • COPAY TIER LEVEL:   2
    COPAY EFFECTIVE DATE:   2017-02-27 00:00:00
PGX ELIGIBLE NO
PGX SUPPRESSED NO
VA PRINT NAME DAUNORUBICIN CITRATE LIPOSOME 2MG/ML INJ
VA PRODUCT IDENTIFIER D0329
TRANSMIT TO CMOP NO
VA DISPENSE UNIT ML
MASTER ENTRY FOR VUID YES
VUID 4003399
EFFECTIVE DATE/TIME
  • 2005-03-10 00:00:00
    STATUS:   ACTIVE
  • 2021-05-17 00:00:00
    STATUS:   INACTIVE
  • 2021-05-17 00:00:00
    STATUS:   INACTIVE
  • 2021-05-17 00:00:00
    STATUS:   INACTIVE